JENNIFER WAREHAM: Open Payments
NPI 1841894227 · TRAVELERS REST, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$958 in 46 payments from 17 companies in 2025. Trend: 2023 $261 · 2024 $358 · 2025 $958
Food & beverage: $907Education: $51
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $175 |
| Janssen Biotech, Inc. | 5 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $108 |
| Regeneron Healthcare Solutions, Inc. | 4 | $108 |
| Ardelyx, Inc. | 6 | $105 |
| GENZYME CORPORATION | 2 | $58 |
| QOL Medical, LLC | 2 | $39 |
| Phathom Pharmaceuticals, Inc. | 2 | $36 |
| Boston Scientific Corporation | 1 | $31 |
| Mallinckrodt Hospital Products Inc. | 1 | $30 |
Products named: DUPIXENT, TREMFYA, RINVOQ, IBSRELA, ENTYVIO, EOHILIA, Sucraid, VOQUEZNA.
Industry payments across SC — which companies pay providers there.
